KARs dysregulation may be at the basis of the drug-resistant seizures and developmental delay described in subjects with genetic mutations linked to other DNA repair proteins as in Breast Cancer 1-associated Ataxia Telangiectasia mutated activation-1 protein (BRAT1) gene [44–46]. This evidence concerns the gene KARS1 and Global developmental delay.